Resultados da busca - Terri Sebree

Caregiver-perceived behavioral challenges in fragile X syndrome and implications for measuring treatment benefit in clinical trials por Elizabeth Merikle, Nancy Tich, Terri Sebree, Randi Hagerman, Stephen O’Quinn, George Nomikos, Kristen Bzdek

Obter o texto integral

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome por Helen Heussler, Jonathan Cohen, Natalie Silove, Nancy Tich, Marcel O. Bonn-Miller, Wei Du, Carol O’Neill, Terri Sebree

Obter o texto integral

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment por Joseph M. Palumbo, Brian F. Thomas, Dejan Budimirovic, Steven Siegel, Flora Tassone, Randi Hagerman, Christopher Faulk, Stephen O’Quinn, Terri Sebree

Obter o texto integral

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX) por Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, Craig Erickson, Helen Heussler, Nicole Tartaglia, Jonathan Cohen, Flora Tassone, Thomas Dobbins, Elizabeth Merikle, Terri Sebree, Nancy Tich, Joseph M. Palumbo, Stephen O’Quinn

Obter o texto integral

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label ext... por Elizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, Dejan Budimirovic, Caroline B. Buchanan, Natalie Silove, Nancy Tich, Anthony Thibodeau, Thomas Dobbins, Terri Sebree, Stephen O’Quinn, David S. Albers, Kristen G. Bzdek, George Nomikos, Kumar Budur

Obter o texto integral